Given the central role of WWOX in restraining HIF1α-driven metabolic reprogramming, therapeutic strategies aimed at restoring WWOX function or inhibiting HIF1α activity hold significant potential to disrupt cancer metabolism and improve patient outcomes. This evidence concerns the gene HIF1A and cancer.